These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32273796)

  • 1. Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells.
    Alhadad LJ; Harisa GI; Alanazi FK
    Saudi Pharm J; 2020 Apr; 28(4):387-396. PubMed ID: 32273796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model.
    Yu L; Wang Y; Yao Y; Li W; Lai Q; Li J; Zhou Y; Kang T; Xie Y; Wu Y; Chen X; Yi C; Gou L; Yang J
    Int J Gynecol Cancer; 2014 Sep; 24(7):1158-64. PubMed ID: 24987913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of HSP27 following HAD-B treatment is associated with Her2 downregulation in NIH:OVCAR-3 human ovarian cancer cells.
    Li KC; Heo K; Ambade N; Kim MK; Kim KH; Yoo BC; Yoo HS
    Mol Med Rep; 2015 Sep; 12(3):3787-3794. PubMed ID: 26044344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.
    Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J
    Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance.
    Hwang SY; Choi SK; Seo SH; Jo H; Shin JH; Na Y; Lee YS; Kwon Y
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model.
    Jiao H; Zhao X; Liu J; Ma T; Zhang Z; Zhang J; Wang J
    Nucl Med Biol; 2019; 68-69():31-39. PubMed ID: 30578135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity.
    Houdaihed L; Evans JC; Allen C
    Pharm Res; 2020 Jan; 37(3):39. PubMed ID: 31965330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides.
    Hong ST; Lin H; Wang CS; Chang CH; Lin AM; Yang JC; Lo YL
    J Nanobiotechnology; 2019 Aug; 17(1):89. PubMed ID: 31426807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab.
    Ma P; Zhang X; Ni L; Li J; Zhang F; Wang Z; Lian S; Sun K
    Int J Nanomedicine; 2015; 10():2173-90. PubMed ID: 25834432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer.
    Shi G; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Zhang R
    Adv Clin Exp Med; 2019 Apr; 28(4):479-487. PubMed ID: 30070081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoproteins induce heat shock protein 27 dephosphorylation, oligomerization, and subcellular relocalization in human vascular smooth muscle cells.
    García-Arguinzonis M; Padró T; Lugano R; Llorente-Cortes V; Badimon L
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1212-9. PubMed ID: 20378850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
    Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
    J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability.
    Kang SH; Kang KW; Kim KH; Kwon B; Kim SK; Lee HY; Kong SY; Lee ES; Jang SG; Yoo BC
    BMC Cancer; 2008 Oct; 8():286. PubMed ID: 18834540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR
    Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.
    Ellsworth JL; Chandrasekaran C; Cooper AD
    Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):175-87. PubMed ID: 1930137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.
    Pavan S; Musiani D; Torchiaro E; Migliardi G; Gai M; Di Cunto F; Erriquez J; Olivero M; Di Renzo MF
    Int J Cancer; 2014 Mar; 134(6):1289-99. PubMed ID: 23996744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL-R promoting activity of peptides derived from human PCSK9 catalytic domain (153-421): design, synthesis and biochemical evaluation.
    Alghamdi RH; O'Reilly P; Lu C; Gomes J; Lagace TA; Basak A
    Eur J Med Chem; 2015 Mar; 92():890-907. PubMed ID: 25679794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies.
    Lopes-Virella MF; Griffith RL; Shunk KA; Virella GT
    Arterioscler Thromb; 1991; 11(5):1356-67. PubMed ID: 1911721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological effect of chrom-4-one derivatives as functional inhibitors of heat shock protein 27.
    Hwang SY; Kwak SY; Kwon Y; Lee YS; Na Y
    Eur J Med Chem; 2017 Oct; 139():892-900. PubMed ID: 28869891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat Shock Protein HSP27 Secretion by Ovarian Cancer Cells Is Linked to Intracellular Expression Levels, Occurs Independently of the Endoplasmic Reticulum Pathway and HSP27's Phosphorylation Status, and Is Mediated by Exosome Liberation.
    Stope MB; Klinkmann G; Diesing K; Koensgen D; Burchardt M; Mustea A
    Dis Markers; 2017; 2017():1575374. PubMed ID: 28325957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.